Ocupress

Active Ingredient(s): Carteolol
FDA Approved: * May 23, 1990
Pharm Company: * NOVARTIS
Category: Vision / Eye Health

Carteolol is a non-selective beta blocker used to treat glaucoma. It has been found to act as a serotonin 5-HT1A and 5-HT1B receptor antagonist in addition to being a beta blocker.[1] It was patented in 1972 and approved for medical use in 1980.[2] Brand names Brand names include Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, and Singlauc. References... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Related Brands

Drugs with the same active ingredients